IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Journal of Emergency Medicine Case Reports
  • Volume:9 Issue:1
  • Methimazole-Induced Febrile Neutropenia

Methimazole-Induced Febrile Neutropenia

Authors : Behçet VARIŞLI, Sinan YILDIRIM, Hatice KARAÇAM, Şehnaz PAKER
Pages : 13-15
View : 22 | Download : 8
Publication Date : 2018-01-01
Article Type : Other Papers
Abstract :Introduction: Antithyroid drugs insert ignore into journalissuearticles values(ATD); are commonly used for the treatment of thyrotoxicosis, particularly for the treatment of Grave’s disease. Methimazole is the first line ATD. A major fatal adverse effect of ATDs, if unrecognized and not treated on time, is agranulocytosis, which is defined as an absolute neutrophil count of <500/μL. The incidence of ATD-induced agranulocytosis is 0.1%–0.3% insert ignore into journalissuearticles values(1);. In this study, we report on a patient who developed granulocytopenic febrile neutropenia at 3 months after treatment with methimazole insert ignore into journalissuearticles values(5 mg twice a day per os insert ignore into journalissuearticles values(BID PO););.Case report: A 51-year-old female patient presented to the emergency department with complaints of fever, fatigue, and productive cough. Her body temperature was 38.5°C; rales were heard on the mid and basal part of the left lung. Drug history revealed methimazole use insert ignore into journalissuearticles values(10 mg per day over the last 2 months);. The WBC count was 1020/μL, and the neutrophil count was 200/μL. The patients’ baseline WBC differential count and immune status were normal. Following inpatient antibiotic treatment and discontinuation of methimazole, the patient became afebrile within 2 days. After 2 weeks of discontinuation of methimazole, we performed CBC and observed the following: WBC, 5180/μL and neutrophil count, 3280/μL.Conclusion: Patients visiting the emergency department with symptoms of a systemic infection and known to use ATDs should be thoroughly evaluated, and the possibility of drug-induced agranulocytosis developing because of the use of these medications should be considered. It is very important for emergency physicians to recognize this rare patient population and act in a timely manner
Keywords : Methimazole, febrile neutropenia, agranulocytosis, antithyroid drugs, fever, emergency medicine

ORIGINAL ARTICLE URL
VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025